Elevated expression of the neurotrophin-3 (NT-3) receptor TrkC by childhood
medulloblastomas is associated with favorable clinical outcome. Here, we p
rovide evidence that TrkC is more than simply a passive marker of prognosis
. We demonstrate that: (a) medulloblastomas undergo apoptosis in vitro when
grown in the presence of NT-3; (b) overexpression of TrkC inhibits the gro
wth of intracerebral xenografts of a medulloblastoma cell line in nude mice
; and (c) trkC expression by individual tumor cells is highly correlated wi
th apoptosis within primary medulloblastoma biopsy specimens. TrkC-mediated
NT-3 signaling promotes apoptosis by activating multiple parallel signalin
g pathways and by inducing immediate-early gene expression of both c-jun an
d c-fos. Considered collectively, these results support the conclusion that
the biological actions of TrkC activation affect medulloblastoma outcome b
y inhibiting tumor growth through the promotion of apoptosis.